Dr. Bolick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3973 E Little Cottonwood Lane
Sandy, UT 84092Phone+1 801-790-0947
Education & Training
- London School of Hygiene and Tropical MedicineMSc, Infectious Disease , 2009 - 2014
- University of UtahM.P.H., 2008 - 2009
- Stanford Health Care-Sponsored Stanford University Surgical PathologyFellowship, Selective Pathology, 1989 - 1990
- Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1986 - 1989
- Duke University School of MedicineClass of 1986
- Brigham Young UniversityB.S., Medical Technology and Microbiology, Summa Cum Laude, 1974 - 1982
Certifications & Licensure
- AZ State Medical License 2004 - Present
- UT State Medical License 2013 - 2026
- WY State Medical License 2006 - 2008
- NV State Medical License 1995 - 2005
- VA State Medical License 2000 - 2002
- ID State Medical License 1990 - 1992
- NC State Medical License 1987 - 1992
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Fellow College of American Pathologists
Publications & Presentations
PubMed
- 77 citationsComparison of the Surepath™ liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial studyMaurice Fremont-Smith, James Marino, Bryan Griffin, Lynn Spencer, David Bolick
Cancer. 2004-10-25 - 16 citationsPedunculated scrotal mass: Leiomyoma of scrotumAnurag K. Das, David Bolick, Nancy A. Little, Philip J. Walther
Urology. 1992-04-01 - 107 citationsLaboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system.David R. Bolick, Dennis J. Hellman
Acta Cytologica. 1998-01-01
Journal Articles
- HPV testing in liquid cytology specimens: comparison of analytic sensitivity and specificity for in situ hybridization and chemiluminescent nucleic acid testingMN Qureshi, D Bolick, PJ Ringer, FL Spangler, G Zimmerman, Acta Cytol, 1/1/2005
- Laboratory Implementation and Efficacy Assessment of the ThinPrep cervical cancer screening systemDR Bolick, D Hellman, Acta Cytologica, 1/1/1998
- The pedunculated scrotal mass: leiomyoma of scrotumAK Das, DR Bolick, NA Little, PJ Walther, Urology, 1/1/1992
- Join now to see all
Abstracts/Posters
- hc2 HPV Testing with the MonoPrep Pap Test: Clinical Demonstration of Performance and Stability for HPV results, CIN2+, and QNS Elimination.B Holladay, D Bolick, J T Molina, T A Alonzo, G E Gammerman, Cancer Cytopathology; Am Society of Cytopathology, 1/1/2007
- MonoPrep detection of CIN2+ and Cancer: Follow up Histocorrelation results from the MPPT PMA Study for MPPT, Pap Smear and the hc2 HPV test.D Bolick, J T Molina, D Davey, E S Cibas, T A Alonzo, G E Gammerman, Cancer Cytopathology; Am Society of Cytopathology, 1/1/2007
- Pap Test Adequacy: Are our Criteria Satisfactory?DR Bolick, British Society of Clinical Cytology, Edinburgh, Scotland, United Kingdom, 1/11/2006
- Join now to see all
Lectures
- Perfecting Patient CarePittsburgh, PA; Aurora, CO - 1/1/2008
- Rational Approaches to Cervical Cancer ScreeningUniversity of Utah - 1/1/2007
- HPV testingUniversity of Utah - 1/1/2007
- Join now to see all
Other
- HPV Testing: Operation and Economic IssuesBolick DR, Papanicolaou Society of Cytology, Semiannual Newsletter Spring
1/1/2004 - HPV Testing: Are your ready for a New Era in Cervical Cancer Screening?Bolick DR, CAP Strategic Science Seminar
- Chlamydia Trachomatis Neisseria Gonorrhoeae By DNA Probe Testing.Bolick DR, RPS technical update
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: